Congressional hearings, media cycles, and public outrage continue to orbit Anthony Fauci. He is summoned, questioned, and cast as the central figure in the pandemic’s mismanagement and the research that preceded it. This focus is understandable. It is also largely performative. Treating Fauci as the primary target ensures the larger structure that funded high-risk pathogen work, managed the response, and extracted extraordinary profits remains intact.
Fauci served as the visible face of NIAID and the public health response. He defended policies, shifted guidance, and was linked to grants that supported coronavirus research through EcoHealth Alliance and collaborations involving the Wuhan Institute of Virology. Those connections are real and deserve scrutiny. Yet the decisions that enabled gain-of-function-style experiments—genetic alterations designed to enhance viral traits—were institutional. They involved funding agencies, review boards, academic laboratories in the United States, and Chinese partners. The bureaucratic language of “gain-of-function” and later “enhanced potential pandemic pathogens” softened the description of deliberate enhancement of dangerous traits. The system that approved and financed that work was never solely one official.
China’s opacity compounds the problem. Early data, laboratory records, and researcher interviews were restricted. Whistleblowers and independent reporters faced silencing. U.S. intelligence noted illnesses among Wuhan researchers in late 2019. None of this has produced full, independent access. An authoritarian regime protecting its image is unsurprising. What is more revealing is the limited pressure applied by Western institutions that once partnered with those same laboratories.
On the commercial side the outcome is clearer. Vaccine manufacturers recorded tens of billions in revenue under liability protections and government purchase contracts. The same networks that shaped research priorities later shaped the response and messaging. Revolving doors, advisory roles, and regulatory capture are not secrets. They are features of the system.
Hearings generate headlines and occasional debarments. They rarely produce structural reform: transparent grant decision trails, enforceable bio-safety standards with real consequences, independent investigation with subpoena power over both domestic agencies and foreign partners, or removal of blanket liability shields that socialize risk while privatizing reward. Political theater substitutes for accountability.
Fauci can be criticized for specific statements, funding choices, and public messaging. Elevating him into the singular villain allows the apparatus—funding bodies, dual-use research incentives, pharmaceutical interests, and protected institutional relationships—to continue operating with minimal disruption. The real culprits are not one man. They are the protected networks that decide which experiments proceed, which data remain sealed, and which profits are guaranteed. Until those networks face sustained, evidence-driven pressure rather than staged questioning, nothing of consequence will change. -WAA
+ There are no comments
Add yours